A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 770,800 shares of GH stock, worth $22 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
770,800
Previous 793,900 2.91%
Holding current value
$22 Million
Previous $16.4 Million 35.91%
% of portfolio
0.05%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.07 - $31.84 $371,217 - $735,504
-23,100 Reduced 2.91%
770,800 $22.3 Million
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $229,542 - $360,594
-13,400 Reduced 1.66%
793,900 $16.4 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $2.72 Million - $3.72 Million
-126,000 Reduced 13.5%
807,300 $21.8 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $4.83 Million - $7.48 Million
187,100 Added 25.07%
933,300 $27.7 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $7.52 Million - $13.7 Million
359,200 Added 92.82%
746,200 $26.7 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $4.83 Million - $7.11 Million
210,700 Added 119.51%
387,000 $9.07 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $3.12 Million - $7.34 Million
122,800 Added 229.53%
176,300 $4.8 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $995,447 - $1.39 Million
22,800 Added 74.27%
53,500 $2.88 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $884,774 - $2.37 Million
30,700 New
30,700 $1.24 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $167,909 - $224,688
-1,700 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $2.67 Million - $4.03 Million
-24,300 Reduced 93.46%
1,700 $211,000
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $3.3 Million - $4.66 Million
26,000 New
26,000 $3.97 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.92B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.